Sedentary Interruptions + Exercise for Reducing Type 2 Diabetes Risk in Children
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to lower the risk of type 2 diabetes in children by comparing different activity patterns. Researchers aim to determine if breaking up sitting time with short walks (SIT+WALK) is more effective than one longer exercise session (EX) at improving health markers like metabolism and heart function. The trial targets children aged 8 to 11 with a higher body mass index (BMI) who are at risk for diabetes. Participants will either sit continuously, take a single 18-minute walk, or interrupt sitting with brief walks every half hour. The study seeks effective strategies to prevent obesity-related diseases in children. As an unphased trial, it offers a unique opportunity for children to contribute to important research that could lead to healthier lifestyles.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those using medications that affect body weight or composition.
What prior data suggests that these interventions are safe for children?
Previous studies have shown that moderate exercise, such as brisk walking, safely and effectively reduces the risk of type 2 diabetes in both children and adults. Research indicates that it can lower blood sugar levels and improve the body's use of insulin to break down sugar.
For the SIT+WALK treatment, studies have found that taking short walks during long periods of sitting can lower insulin and sugar levels in the blood. This method has been tested in both adults and children and appears to safely improve blood sugar control.
Both treatments focus on increasing physical activity, which most people can handle easily. Significant negative effects have not been reported. Overall, these strategies seem safe and could benefit children at risk of diabetes.12345Why are researchers excited about this trial?
Researchers are excited about these techniques because they offer a fresh approach to reducing the risk of Type 2 Diabetes in children through simple lifestyle changes. Unlike typical treatments that might involve medication or extensive exercise routines, these methods focus on breaking up long periods of sitting with short bursts of moderate walking. The SIT+WALK approach, in particular, encourages kids to take 3-minute walking breaks every 30 minutes, making it an accessible and less daunting way to stay active. This trial aims to find out if these manageable interruptions can significantly impact health, presenting a potentially easy and effective strategy for diabetes prevention that fits into daily life without major disruption.
What evidence suggests that this trial's treatments could be effective for reducing type 2 diabetes risk in children?
Research has shown that taking short breaks to move around, such as walking, during long periods of sitting can help children who are overweight or obese process sugar more effectively. In this trial, participants in the SIT+WALK arm will interrupt sitting with 3-minute walks every 30 minutes. These quick activity breaks can lower blood sugar and insulin levels, which are important for preventing type 2 diabetes. Studies have found that these breaks can lead to better overall heart and metabolic health. Alternatively, participants in the EX arm will perform one longer session of moderate walking, which can initially help manage blood sugar levels, though the benefits might not last as long. Both approaches show promise for reducing the risk of type 2 diabetes in children.678910
Are You a Good Fit for This Trial?
This trial is for children aged 7-11 who are overweight or obese, with a BMI in the top 15% for their age. They must have normal fasting blood sugar levels and be generally healthy without any significant heart or lung diseases, endocrine disorders like Cushing Syndrome, or treatments affecting body weight.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a fitness test, body composition analysis, and baseline activity and heart rate variability monitoring
Treatment
Participants undergo 7 consecutive days of experimental conditions (SIT, SIT+WALK, or EX) with continuous glucose monitoring and ECG monitoring
Follow-up
Participants are monitored for changes in metabolic, cognitive, affective, and cardiac autonomic nervous system outcomes
What Are the Treatments Tested in This Trial?
Interventions
- EX
- SIT+WALK
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Southern California
Lead Sponsor
Children's Hospital Los Angeles
Collaborator
Dana-Farber Cancer Institute
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator